CorMedix sets $75M stock buyback plan
Source: SeekingAlpha
2026-02-02 09:06:17 ET
More on CorMedix
- CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade)
- CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge
- CorMedix shares fall as 2026 revenue outlook disappoints (update)
- CorMedix raises 2025 revenue guidance to $390M-$410M amid accelerated Melinta integration and DefenCath momentum
Read the full article on Seeking Alpha
For further details see:
CorMedix sets $75M stock buyback plan
CorMedix Inc.
NASDAQ: CRMD
CRMD Trading
-2.55% G/L:
$7.08 Last:
553,740 Volume:
$7.20 Open:
CRMD Latest News
January 29, 2026 08:30:00 am
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
January 14, 2026 09:58:00 am
Lost Money on CorMedix Inc. (CRMD)? Contact Levi & Korsinsky About Fraud Investigation
January 09, 2026 08:30:00 am
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
CRMD Stock Data
$605,887,756
76,346,585
2.82%
76
N/A
Biotechnology & Life Sciences
Healthcare
US
Berkeley Heights
